Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

Xijing Hospital is the lead sponsor of 129 current clinical trials in our China register. 81 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Aspirin, Clopidogrel and Rivaroxaban. The most-studied condition is Breast Cancer.

ClinicalTrials.gov trials by status

Recruiting8163%
Not yet open2318%
Active, closed1713%
By invitation86%

Trials by phase

Not applicable6147%
Observational4233%
Phase 2108%
Phase 343%
Phase 1/232%
Phase 132%
Phase 422%
Phase 2/322%
Phase EARLY_PHASE122%

Clinical trials sponsored by Xijing Hospital

129 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Transcatheter Aortic Valve Replacement for Pure Severe Aortic Valve Regurgitation NCT06381271 · Aortic Valve Regurgitation	Observational	Recruiting	2018-10	China
Development and Validation of an Anxiety Disorder Prediction Model for Premature Ejaculation Patients NCT06677814 · ClinicalTrials.gov ↗ · Premature Ejaculation, Anxiety	Observational	Recruiting	2024-03	China
A Prospective, Interventional, Exploratory Study Evaluating the Efficacy of Small-Molecule Compound XJH05 Ointment in the Treatment of Plaque Psoriasis NCT07780929 · ClinicalTrials.gov ↗ · Psoriasis, Psoriasis (PsO)	Not applicable	Recruiting	2025-11	China
Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds NCT05032053 · ClinicalTrials.gov ↗ · Ischemic Stroke	Observational	Recruiting	2022-03	China
Picankibart in Palmoplantar Pustulosis NCT07552454 · ClinicalTrials.gov ↗ · Palmoplantar Pustulosis Drug: Picankibart	Not applicable	Recruiting	2026-04	China
Postoperative Delirium in Patients Undergoing Cardiac Surgery NCT07239648 · ClinicalTrials.gov ↗ · Postoperative Delirium	Observational	Recruiting	2025-10	China
Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis NCT06231264 · ClinicalTrials.gov ↗ · Ulcerative Colitis	Not applicable	Recruiting	2024-01	China
Serum Adiponectin in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases NCT01372800 · ClinicalTrials.gov ↗ · Myocardial Infarction, Cerebral Infarction	Observational	Recruiting	2011-05	China
LAAO Versus NOAC in Patients with AF and PCI NCT05353140 · ClinicalTrials.gov ↗ · Atrial Fibrillation, Percutaneous Coronary Intervention Drugs: Aspirin, Clopidogrel, Rivaroxaban	Not applicable	Recruiting	2022-09	China
3D-printed Biodegradable Breast Implants for Breast Restoration NCT06993714 · ClinicalTrials.gov ↗ · Breast Cancer, Breast Reconstruction	Phase 2	Recruiting	2025-05	China
Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis NCT07553754 · ClinicalTrials.gov ↗ · Prostate Cancer (Diagnosis), Bone Metastasis, PSMA PET	Observational	Recruiting	2026-03	China
Research on the Potential Mechanisms Underlying the Efficacy Differences in Specific Neoadjuvant Treatment Regimens for Different Subtypes of Breast Cancer NCT07012720 · ClinicalTrials.gov ↗ · Breast Cancer	Not applicable	Recruiting	2024-04	China
Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis NCT06359808 · ClinicalTrials.gov ↗ · Colitis, Ulcerative, Sleep Quality, Gastrointestinal Microbiome	Observational	Recruiting	2024-04	China
Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease NCT06572267 · ClinicalTrials.gov ↗ · Coronary Artery Disease	Phase 2	Recruiting	2024-10	China
Transcutaneous Electrical Acupoint Stimulation at Jing-Well Points for Disorders of Consciousness NCT07535593 · ClinicalTrials.gov ↗ · Disorders of Consciousness Due to Severe Brain Injury	Phase 2/3	Recruiting	2026-04	China
Olverembatinib Plus Venetoclax and Dexamethasone for Treatment-naïve Ph+ Acute Lymphoblastic Leukemia NCT06082934 · ClinicalTrials.gov ↗ · Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia Drug: Olverembatinib	Phase 1/2	Recruiting	2023-11	China
The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV NCT05690802 · ClinicalTrials.gov ↗ · Nausea and Vomiting Drug: Palonosetron hydrochloride	Not applicable	Recruiting	2022-05	China
Comparing the Components of Composite Endpoints for Healthcare Providers and Patients NCT07378137 · ClinicalTrials.gov ↗ · Coronary Artery Disease, Percutaneous Coronary Intervention	Observational	Recruiting	2025-08	China
Long-term Prognosis and Valve Durability of TAVR NCT06379386 · ClinicalTrials.gov ↗ · Aortic Valve Stenosis and Insufficiency	Observational	Recruiting	2016-01	China
Early Neurovascular Decoupling Trajectories After Revascularization in Acute Ischemic Stroke NCT07405762 · ClinicalTrials.gov ↗ · Ischemic Stroke	Observational	Recruiting	2026-02	China
Transcutaneous Electrical Nerve Stimulation (TENS) for the Treatment of Low Back Pain (LBP) in Adults NCT07368920 · ClinicalTrials.gov ↗ · Low Back Pain, Paraspinal Muscles, CLBP - Chronic Low Back Pain	Not applicable	Recruiting	2026-02	China
Study on the Preferences for PCI Implantation Devices Among Doctors and Patients NCT07378163 · ClinicalTrials.gov ↗ · Coronary Artery Disease, Percutaneous Coronary Intervention	Observational	Recruiting	2025-08	China
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass NCT06702553 · ClinicalTrials.gov ↗ · Nitric Oxide, Cardiac Surgery, Cardiopulmonary Bypass	Phase 3	Recruiting	2025-05	China
Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases （ACT-AD） NCT06669182 · ClinicalTrials.gov ↗ · Alzheimer Disease, Transcranial Magnetic Stimulation, Cerebellum	Not applicable	Recruiting	2025-01	China
Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer NCT06914440 · ClinicalTrials.gov ↗ · Breast Cancer Drug: Toripalimab	Phase 2	Recruiting	2025-06	China
Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis NCT06082531 · ClinicalTrials.gov ↗ · Platelets-rich Plasma, Osteoarthritis Knees Both, Meniscus Disorder Drug: Sodium Hyaluronate	Not applicable	Recruiting	2023-09	China
Single-arm, Phase II Clinical Study Evaluating the Safety and Efficacy of Sintilimab Combined With IBI-310 and Chemotherapy as Neoadjuvant Therapy for Locally Advanced Rectal Cancer NCT07750951 · ClinicalTrials.gov ↗ · MSI-H/dMMR Locally Advanced Rectal Adenocarcinoma	Phase 2	Recruiting	2026-05	China
A Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surgery NCT07071402 · ClinicalTrials.gov ↗ · Breast Cancer (Early Breast Cancer)	Not applicable	Recruiting	2025-07	China
Low-dose NOAC Versus GDMT After LAAO NCT05960721 · ClinicalTrials.gov ↗ · Atrial Fibrillation Drugs: Aspirin, Clopidogrel, Rivaroxaban	Not applicable	Recruiting	2023-07	China
Oral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter RCT NCT06900777 · ClinicalTrials.gov ↗ · Vitiligo, Child, Progressive Disease Drugs: Dexamethasone, Tacrolimus	Not applicable	Recruiting	2025-04	China
Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China NCT06830499 · ClinicalTrials.gov ↗ · AORTIC VALVE DISEASES, Bicuspid Aortic Valve (BAV)	Observational	Recruiting	2025-04	China
Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers NCT07600125 · ClinicalTrials.gov ↗ · Gastric Cancer, Colorectal Cancer	Observational	Recruiting	2026-08	China
A Study on Gastrointestinal Cancer Screening Using a Multi-Targeted Combined Detection Model NCT07712107 · ClinicalTrials.gov ↗ · Gastrointestinal Tumors	Not applicable	Recruiting	2026-06	China
Investigation of the Correlation Between Polyamine Levels and Their Key Enzymatic Activities in Association With Inflammatory Bowel Disease Progression NCT06995170 · ClinicalTrials.gov ↗ · Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease	Observational	Recruiting	2025-01	China
Desflurane vs. Propofol for Cardiac Anesthesia NCT07116733 · ClinicalTrials.gov ↗ · Cardiac Surgery, Coronary Artery Bypass Grafting	Phase 3	Recruiting	2025-10	China
Researching the Useful of Barb Suture in Obese Patients Undergoing Posterior Cervical Surgery NCT05895968 · ClinicalTrials.gov ↗ · Cervical Spinal Stenosis, Posterior Cervical Spine Surgery, Barbed Suture	Not applicable	Recruiting	2023-01	China
Exploratory Study With Parallel Controls on the Safety and Efficacy of Neoadjuvant Low Branched-Chain Amino Acid Diet in Combination With Anti-PD-1 Monoclonal Antibody for Stage III Melanoma NCT07586891 · ClinicalTrials.gov ↗ · Melanoma (Skin Cancer)	Not applicable	Recruiting	2024-07	China
A Single-Center, Retrospective, Propensity-Score-Matched Cohort Study Comparing Drug-Coated Balloon Versus Drug-Eluting Stent for Reducing Immediate Post-Procedural Slow-Flow/No-Reflow in Acute ST-Elevation Myocardial Infarction Patients With High Thrombus Burden NCT07806370 · ClinicalTrials.gov ↗ · ST Elevation Myocardial Infarction (STEMI), Acute Coronary Syndromes (ACS)	Observational	Recruiting	2019-01	China
The Safety and Efficacy Evaluation of Echocardiography-guided Percutaneous Radiofrequency Ablation for Cardiac Tumors: a Single-arm, Prospective, Single-center Clinical Study NCT06830512 · ClinicalTrials.gov ↗ · Heart Neoplasms	Not applicable	Recruiting	2024-01	China
Effect of a Pharmacist-led Multifaceted Intervention on Treatment Outcomes in Hypertensive Patients NCT06558877 · ClinicalTrials.gov ↗ · Hypertension	Not applicable	Recruiting	2025-06	China
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal Carcinoma NCT06979869 · ClinicalTrials.gov ↗ · Esophageal Cancer	Observational	Recruiting	2025-05	China
A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis NCT07270003 · ClinicalTrials.gov ↗ · Palmoplantar Pustulosis (PPP)	Not applicable	Recruiting	2025-10	China
A Clinical Study Comparing Anti-HER2 Therapy Combined With Chemotherapy to Chemotherapy Alone as Adjuvant Therapy Following Surgery for Stage IB-II Gastric Cancer With High HER2 Expression. NCT07788196 · ClinicalTrials.gov ↗ · IB-II Gastric Cancer	Phase 2	Recruiting	2026-07	China
Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients NCT07180368 · ClinicalTrials.gov ↗ · Coronary Artery Disease, Diabete Mellitus, Chronic Kidney Disease	Observational	Recruiting	2024-10	China
Study of Individualized, Precise and Standardized Cervical Open-door Surgery for Cervical Spinal Stenosis NCT05786313 · ClinicalTrials.gov ↗ · Cervical Spinal Stenosis, Cervical Spinal Cord Injury, Individuation	Not applicable	Recruiting	2023-03	China
Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma. NCT07586904 · ClinicalTrials.gov ↗ · Melanoma (Skin Cancer)	Phase EARLY_PHASE1	Recruiting	2025-05	China
Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer NCT06613165 · ClinicalTrials.gov ↗ · Immune-related Adverse Event, Neoadjuvant Therapy, dMMR Colorectal Cancer	Observational	Recruiting	2025-01	China
Colorectal Cancer Dataset in Xijing Hospital From 2011 NCT06308354 · ClinicalTrials.gov ↗ · Prognostic Cancer Model, Chemotherapy, Nutrition Related Cancer	Observational	Recruiting	2011-01	China
Effects of Transcranial Magnetic Stimulation After Endovascular Treatment for Acute Ischemic Stroke NCT06639360 · ClinicalTrials.gov ↗ · Ischemic Stroke, Acute, Endovascular Thrombectomy	Not applicable	Recruiting	2025-08	China
A Population-based, Multicenter Cohort Study of Combined Screening for Gastrointestinal Tumors NCT05996458 · ClinicalTrials.gov ↗ · Digestive Disease	Observational	Recruiting	2023-08	China
Study on the Cosmetic Outcome and Safety Evaluation of 3D Printed Biodegradable Biological Mesh for One-Stage Breast Reconstruction After Radical Mastectomy NCT07365267 · ClinicalTrials.gov ↗ · Breast Cancer, Breast Reconstruction After Mastectomy, 3D-Printed Biodegradable Biological Mesh	Not applicable	Recruiting	2026-01	China
Exploring the Characteristics of Epileptogenic Foci in Drug-Resistant Epilepsy Based on Multimodal Imaging Technology NCT06557720 · ClinicalTrials.gov ↗ · Drug Resistant Epilepsy, Magnetic Resonance Imaging, Electroencephalogram (EEG)	Observational	Recruiting	2024-06	China
A Randomized, Controlled, Open-Label, Multi-center Clinical Study Comparing the Efficacy of Close Follow-Up Versus Adjuvant Chemotherapy in Patients With Stage IB-IIA Gastric or Gastroesophageal Junction Adenocarcinoma Following Radical Surgery NCT07751302 · ClinicalTrials.gov ↗ · Stage IB-IIA Adenocarcinoma of the Stomach or Gastroesophageal Junction	Not applicable	Recruiting	2026-08	China
A Multicenter Prospective Observational Cohort Study for Digestive Tract Tumor Screening Using Multi-Target Blood and Fecal Biomarkers NCT07769892 · ClinicalTrials.gov ↗ · Gastrointestinal Cancers	Observational	Recruiting	2026-08	China
A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC NCT07178171 · ClinicalTrials.gov ↗ · TNBC, Triple Negative Breast Cancer Drugs: Carboplatin, Cyclophosphamide, Iparomlimab and Tuvonralimab	Phase 1	Recruiting	2025-11	China
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer NCT06979895 · ClinicalTrials.gov ↗ · Gastric (Stomach) Cancer	Observational	Recruiting	2025-05	China
Liquid Biopsy Multi-Omics and Biomarker Development in Melanoma NCT07584291 · ClinicalTrials.gov ↗ · Melanoma (Skin Cancer)	Observational	Recruiting	2025-07	China
Correlation Between Parameters and Prognosis of Cervical Single Open-door Surgery NCT05767164 · ClinicalTrials.gov ↗ · Cervical Spinal Stenosis	Not applicable	Recruiting	2023-01	China
Bioresorbable Sirolimus-eluting scaﬀold in de Novo Coronary Artery Lesions NCT07022587 · ClinicalTrials.gov ↗ · De Novo Stenosis, Coronary Artery Disease	Not applicable	Recruiting	2025-12	China
The Feasibility of taVNS on Pregnancy Outcomes of Infertility Patients Undergoing IVF NCT06742788 · ClinicalTrials.gov ↗ · Infertility Assisted Reproductive Technology	Not applicable	Recruiting	2025-03	China
A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT Imaging NCT06834412 · ClinicalTrials.gov ↗ · Hematological Malignancies	Not applicable	Recruiting	2021-11	China
A Study Evaluating the Value of 68Ga-NOTA-RCCB6 PET Imaging for Targeting CD70 in the Clinical Staging, Therapeutic Evaluation, and Restaging of Renal Cell Carcinoma, and Comparing It with 68Ga-PSMA PET/CT Imaging NCT06769893 · ClinicalTrials.gov ↗ · RCC, Renal Cell Cancer	Not applicable	Recruiting	2024-06	China
The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric NCT05956847 · ClinicalTrials.gov ↗ · Gastric Cancer, Precancerous Lesion of Digestive Tract, Extrachromosomal DNA	Observational	Recruiting	2023-08	China
Safety and Efficacy of S103 Cells in Progressive/Refractory Multiple Sclerosis NCT07587125 · ClinicalTrials.gov ↗ · Multiple Sclerosis (MS) Primary Progressive, Multiple Sclerosis, Multiple Sclerosis (MS) Secondary Progressive	Phase 1	Recruiting	2026-05	China
A Study to Evaluate the Diagnostic Efficacy of 68Ga- MY6349 PET/CT in Patients With Tumours NCT06770478 · ClinicalTrials.gov ↗ · Tumour of Epithelial Origin, 68Ga-MY6349	Not applicable	Recruiting	2024-10	China
Exploratory Clinical Trial of Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis. NCT05895981 · ClinicalTrials.gov ↗ · Ulcerative Colitis	Not applicable	Recruiting	2023-07	China
Effect of Postoperative Analgesia of Oliceridine Fumarate for Gastrointestinal Function Recovery in Patients Undergoing Lumbar Spine Surgery NCT07307495 · ClinicalTrials.gov ↗ · Oliceridine Fumarate Drug: Sufentanil	Not applicable	Recruiting	2026-03	China
Transcranial Temporal Interference Stimulation In Severely Brain Injured Patients With Disorders of Consciousness NCT06851156 · ClinicalTrials.gov ↗ · Disorders of Consciousness, Severe Brain Injury, Unresponsive Wakefulness Syndrome	Not applicable	Recruiting	2025-04	China
A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer NCT07474142 · ClinicalTrials.gov ↗ · Newly Diagnosed, Treatment-naïve Prostate Cancer	Observational	Recruiting	2026-03	China
Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer NCT07492927 · ClinicalTrials.gov ↗ · Clinically Significant Prostate Cancer	Observational	Recruiting	2021-03	China
Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy NCT06586242 · ClinicalTrials.gov ↗ · Esophageal Cancer Drugs: Albumin paclitaxel, Anlotinib, Lobaplatin	Phase 2	Recruiting	2023-04	China
Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer NCT07553780 · ClinicalTrials.gov ↗ · High-risk Prostate Cancer, PSMA PET, Treatment Response	Observational	Recruiting	2021-03	China
Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer NCT07531329 · ClinicalTrials.gov ↗ · Treatment-naive Prostate Cancer, Suspected Prostate Cancer, Molecular Imaging	Observational	Recruiting	2021-03	China
Efficacy and Mechanism of rTMS on the Symptoms of Pleasure Deficit in Adolescent Depression NCT06580249 · ClinicalTrials.gov ↗ · Depression	Not applicable	Recruiting	2024-09	China
Temporal Interference Stimulation of Hypothalamus in Patients With Narcolepsy Type 1 NCT07727239 · ClinicalTrials.gov ↗ · Narcolepsy Type 1	Not applicable	Recruiting	2026-08	China
Sodium Aescinate for the Treatment of Low Back Pain (LBP) in Adults NCT07339631 · ClinicalTrials.gov ↗ · Low Back Pain, Paraspinal Muscle, CLBP - Chronic Low Back Pain	Phase 1	Recruiting	2026-03	China
Clinical Efficacy and Safety Assessment of Breast-Conserving Surgery for Central Breast Cancer: A Prospective Randomized Controlled Trial NCT06938360 · ClinicalTrials.gov ↗ · Breast Cancer	Not applicable	Recruiting	2025-02	China
Safety and Efficacy of Post-marketing Transcatheter Aortic Valves in "Real World" Chinese Patients NCT06257043 · ClinicalTrials.gov ↗ · Aortic Valve Disease Mixed	Observational	Recruiting	2023-10	China
Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate Cancer NCT06575257 · ClinicalTrials.gov ↗ · Prostate Cancer Drugs: Darolutamide, Goserelin	Phase 2	Recruiting	2024-05	China
Long-term Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis NCT07114159 · ClinicalTrials.gov ↗ · Ulcerative Colitis	Not applicable	Recruiting	2025-08	China
68Ga-PSMA PET in the Renal Cell Carcinoma NCT04987086 · ClinicalTrials.gov ↗ · Renal Cancer, Metastases, PSMA PET	Not applicable	Recruiting	2021-06	China
Pulsed Field Ablation Versus Radiofrequency Ablation: Effects of Pulmonary Vein Isolation Combined With Left Atrial Posterior Wall Isolation on Postoperative Gastric Motility in Patients With Persistent Atrial Fibrillation NCT07612241 · ClinicalTrials.gov ↗ · Persistent Atrial Fibrillation	Observational	Not yet open	2026-05	China
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Intestinal Carcinoma NCT06979882 · ClinicalTrials.gov ↗ · Intestinal Cancer	Observational	Not yet open	2025-05	China
Nevus Removal vs. Conservative Treatment in Halo Nevus With Vitiligo: A Randomized Study NCT07307534 · ClinicalTrials.gov ↗ · Vitiligo, Halo Nevus	Not applicable	Not yet open	2026-01	China
Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies NCT07014254 · ClinicalTrials.gov ↗ · Pancreatic Ductal Adenocarcinoma (PDAC), Adenocarcinoma of the Stomach, Colorectal Cancer Metastatic	Not applicable	Not yet open	2025-06	China
Long Term Efficacy and Safety of TMS Targeting Cerebellum to Treat DRE NCT06832813 · ClinicalTrials.gov ↗ · Drug-resistant Epilepsy, Transcranial Magnetic Stimulation	Not applicable	Not yet open	2025-03	China
A Real-world HCM-cohort Trial NCT07638033 · ClinicalTrials.gov ↗ · Hypertrophic Cardiomyopathy (HCM)	Observational	Not yet open	2026-06	China
Safety and Quality of Life of Three Treatment Strategies for Low-Risk Papillary Thyroid Microcarcinoma NCT07249125 · ClinicalTrials.gov ↗ · Papillary Thyroid Microcarcinoma	Observational	Not yet open	2025-12	China
Prizvalve Transcatheter Aortic Valve in Failing Bioprosthetic Valves NCT07122050 · ClinicalTrials.gov ↗ · Failing Bioprosthetic Valves	Not applicable	Not yet open	2025-08	China
A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer NCT06769919 · ClinicalTrials.gov ↗ · Breast Cancer	Phase 2/3	Not yet open	2024-12	China
Optimal LDL-C Target in High-risk Patients After PCI NCT06821711 · ClinicalTrials.gov ↗ · Chronic Coronary Syndrome, Acute Coronary Syndromes, Percutaneous Coronary Intervention	Not applicable	Not yet open	2025-02	China
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Heat Stroke NCT05155358 · ClinicalTrials.gov ↗ · Heat Stroke, Early Waking, MODS	Observational	Not yet open	2025-08	China
Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma NCT05539118 · ClinicalTrials.gov ↗ · Melanoma Drugs: Anlotinib hydrochloride, Toripalimab	Phase 1/2	Not yet open	2022-09	China
Evaluating the Effectiveness of 68Ga-grazytracer PET/CT in Inflammatory Bowel Disease NCT07022080 · ClinicalTrials.gov ↗ · Inflammatory Bowel Diseases (IBD)	Not applicable	Not yet open	2025-06	China
Precision Transcranial Magnetic Stimulation for Depression Based on Orbital Frontal Cortex-habenula Circuitry NCT06837207 · ClinicalTrials.gov ↗ · Depression, Transcranial Magnetic Stimulation	Not applicable	Not yet open	2025-03	China
Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock NCT07129031 · ClinicalTrials.gov ↗ · Hemorrhage, Hemorrhagic Shock, Upper Gastrointestinal Bleeding (UGIB)	Phase 3	Not yet open	2025-09	China
Building an Assessment Model for Vitiligo Activity and Prognosis Using Peripheral Blood Cytokine Profiles NCT07298551 · ClinicalTrials.gov ↗ · Vitiligo	Observational	Not yet open	2025-12	China
Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast Cancer NCT07532096 · ClinicalTrials.gov ↗ · Breast Cancer	Not applicable	Not yet open	2026-04	China
The Effect of Esketamine on Postoperative Cognitive Function in Elderly Patients Undergoing Oral and Maxillofacial Surgery NCT07665099 · ClinicalTrials.gov ↗ · Perioperative Neurocognitive Disorders Drug: Esketamine	Not applicable	Not yet open	2026-07	China
Temporal Interference for Temporal Lobe Epilepsy Under SEEG NCT07082101 · ClinicalTrials.gov ↗ · Epilepsy	Not applicable	Not yet open	2025-08	China

Showing the 100 most recently updated of 129 trials (recruiting first). The rest are in the country registers linked in each row.

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Xijing Hospital trials

30 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Conditions in Xijing Hospital trials

193 conditions

Breast Cancer9 Coronary Artery Disease6 Percutaneous Coronary Intervention4 Vitiligo4 Ulcerative Colitis3PSMA PET3Transcranial Magnetic Stimulation3Cervical Spinal Stenosis3Melanoma (Skin Cancer)3Ischemic Stroke, Acute2Psoriasis (PsO)2Ischemic Stroke2 Atrial Fibrillation2Angioplasty, Balloon2Colitis, Ulcerative2Low Back Pain2CLBP - Chronic Low Back Pain2Cardiac Surgery2Endovascular Thrombectomy2Hypertension2 Esophageal Cancer2 Epilepsy2 Depression2De Novo Stenosis2

By trial register

Register	Trials	Recruiting
Clinical trials in China	129	81

A trial with sites in more than one country appears in each of those registers; recruiting counts cover the trials listed on this page.

Other sponsors in Breast Cancer

Sponsor	Trials
Fudan University	48
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	21
Second Affiliated Hospital, Zhejiang University, School of Medicine	19
AstraZeneca	15
Shengjing Hospital	15
Pfizer	12
Sichuan Baili Pharmaceutical	12
Cancer Institute and Hospital, Chinese Academy of Medical Sciences	12
Hoffmann-La Roche	10
Ruijin Hospital	10

Sponsors with the most current trials registered for this condition.

Questions about Xijing Hospital trials

How many clinical trials does Xijing Hospital sponsor?

Xijing Hospital is the lead sponsor of 129 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Xijing Hospital trials recruiting?

Yes. 81 of its 129 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Xijing Hospital testing?

Its current trials name 30 drugs and biologicals as interventions. The most frequent are Aspirin (2), Clopidogrel (2), Rivaroxaban (2), Serplulimab (2) and Tacrolimus (2). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Xijing Hospital clinical trials